TERT and neoplasm: Furthermore, regardless of concomitant gene alterations, TERT promoter mutation is predominant among older patients and in larger tumors, as well as being strongly associated with extrathyroidal invasion, angiogenesis, tumor recurrence, and mortality [70,72].